年龄校正D-二聚体截断值在非高验前概率静脉血栓栓塞排除中的临床性能与成本效果分析
该研究回顾性比较了基于三级Wells评分和不同D-二聚体截断值的六种诊断策略,在644例非高验前概率门诊患者中评估,发现年龄校正截断值(>50岁者年龄×10)表现最佳,特异性与阴性预测值(NPV)均优于固定截断值500 ng/ml。随后在1255例连续门诊患者的多中心验证中确认NPV仍高于99%,并显示该策略使肺栓塞诊断成本降低6.9%、深静脉血栓降低5.1%。
要点
- 年龄校正D-二聚体截断值(>50岁年龄×10)在非高验前概率患者中安全排除VTE,NPV>99%。
- 该策略较固定截断值500 ng/ml提高特异性,减少不必要的影像学检查。
- 基于本地报销率,该策略分别降低肺栓塞和深静脉血栓诊断成本6.9%和5.1%。
核心结论
- 在>50岁非高验前概率患者中,基于年龄校正D-二聚体截断值的VTE诊断策略安全(NPV>99%)且具有成本效益。
研究设计与样本
- 回顾性衍生队列研究纳入644例非高验前概率门诊患者,比较六种基于三级Wells评分和不同D-二聚体截断值的诊断策略。
- 多中心验证研究纳入1255例连续非高验前概率门诊患者,确认最佳策略的临床实用性。
- D-二聚体检测采用HemosIL D-Dimer HS 500测定法。
主要发现
- 年龄校正截断值(>50岁者年龄×10)在衍生研究中表现最佳,灵敏度与特异性比值优于固定截断值500 ng/ml。
- 年龄校正策略具有更高特异性和阴性预测值(NPV)>99%。
- 验证队列中确认特异性提高,NPV仍>99%。
关键数值与推荐
- 年龄校正D-二聚体截断值计算方法:>50岁患者年龄乘以10。
- 固定截断值对照为500 ng/ml。
- 年龄校正策略NPV>99%。
- 诊断成本降低:肺栓塞6.9%,深静脉血栓5.1%。
临床怎么用
- 对>50岁非高验前概率疑似VTE门诊患者,可采用年龄校正D-二聚体截断值(年龄×10)替代固定500 ng/ml以提高特异性。
- 该策略可安全减少影像学检查需求,并降低诊断成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As aging was found to be associated with increased D-dimer levels, the question arose whether D-dimer measurement was useful in the diagnostic strategy of venous thromboembolism (VTE) in elderly patients. AIM OF THE STUDY: To compare retrospectively the performance of six diagnostic strategies based on the three-level Wells scores and various cut-off levels for D-dimer, evaluated using the HemosIL D-Dimer HS 500 assay, in a derivation cohort of 644 outpatients with non-high pretest probability (PTP) of VTE. The clinical usefulness of the best-performing strategy was then confirmed in a multicenter validation study involving 1255 consecutive outpatients with non-high PTP. RESULTS: The diagnostic strategy based on the age-adjusted cut-off level calculated by multiplying the patient's age by 10 above 50 years was found to perform the best in the derivation study with a better sensitivity-to-specificity ratio than the conventional strategy based on the fixed cut-off level (500 ng/ml), a higher specificity and a negative predictive value (NPV) above 99%. Such an increase in test specificity was confirmed in the validation cohort, with the NPV remaining above 99%. Taking into account the local reimbursement rates of diagnostic tests, using this strategy led to a 6.9% reduction of diagnostic costs for pulmonary embolism and a 5.1% reduction for deep vein thrombosis, as imaging tests would be avoided in a higher percentage of patients. CONCLUSION: The diagnostic strategy of VTE based on the age-adjusted cut-off level for D-dimer in patients over 50 years was found to be safe, with NPV above 99%, and cost-effective.
引用
- De Pooter N, Brionne-François M, Smahi M, et al. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in patients with non-high pre-test probability: Clinical performance and cost-effectiveness analysis. J Thromb Haemost. 2021. PMID: 33638267. doi:10.1111/jth.15278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。